Table 1 Clinicopathological characteristics of patients enrolled in this study
From: Expression of serum amyloid A in uterine cervical cancer
| Characteristics | RT-PCR | IHC | ELISA | |||
|---|---|---|---|---|---|---|
| Number | Percentage (%) | Number | Percentage (%) | Number | Percentage (%) | |
| Histological type | ||||||
| Adenocarcinoma | 2 | 6.4 | 4 | 19.0 | 6 | 4.3 |
| Squamous cell carcinoma | 19 | 61.3 | 12 | 57.1 | 66 | 47.8 |
| CIN | 0 | 0 | 34 | 24.6 | ||
| Uterine fibroids | 10 | 32.3 | 5 | 23.9 | 21 | 15.2 |
| Endometrial polyps | 0 | 0 | 5 | 3.6 | ||
| Ovarian cysts | 0 | 0 | 6 | 4.3 | ||
| Grade of tumor | ||||||
| Well differentiated | 2 | 9.5 | 4 | 25 | 19 | 26.4 |
| Moderately differentiated | 2 | 9.5 | 5 | 31.3 | 11 | 15.3 |
| Poorly differentiated | 17 | 81.0 | 7 | 43.7 | 42 | 58.3 |
| Histological stage | ||||||
| CINI | 1 | 2.9 | ||||
| CINII | 5 | 14.7 | ||||
| CINIII | 28 | 82.4 | ||||
| FIGO stage (Pre-NAC) | ||||||
| Ia | 0 | 2 | 12.5 | 3 | 4.1 | |
| Ib | 12 | 57.1 | 6 | 37.5 | 30 | 41.7 |
| IIa | 6 | 28.6 | 5 | 31.3 | 30 | 41.7 |
| IIb | 3 | 14.3 | 3 | 18.7 | 9 | 12.5 |
| Lymph node metastasis | ||||||
| Negative | 10 | 47.6 | 5 | 31.3 | 21 | 29.2 |
| Positive | 11 | 52.4 | 11 | 68.7 | 51 | 70.8 |